Veterinary ophthalmology is experiencing a revolution in diagnostic tools. The latest JAVMA supplemental issue will open your eyes to the latest…

The U.S. Department of Justice is seeking to reclassify marijuana from a highly restricted Schedule I drug to a less tightly regulated Schedule III…

Seventeen organizations sent a joint letter that encourages agriculture and state government leaders to wait for results of safety studies before…

Read recent news articles about governmental actions and developments affecting the veterinary profession, written by the AVMA News team.

In October, licensed veterinarians in the Silver State can recommend and administer hemp and CBD products, yet many questions remain about the drug’s…

White-nose syndrome, cancer treatment aid, CBD in dogs

A range of issues were covered at the first AVMA Cannabis Symposium, from regulatory and toxicological concerns to the drug’s potential as a…

The AVMA House of Delegates discussed how busy their practices are now, concerns they have for keeping themselves and their staff healthy, how to…

Resources to help veterinarians advise clients and treat patients who may have been exposed to marijuana, the most commonly used illicit drug in the…

The hearing is part of an FDA plan resulting from growing interest in FDA-regulated products derived from Cannabis sativa L and its components.

Get answers to frequently asked questions about the regulatory status of cannabis, cannabis-derived, and cannabis-related products in veterinary…

The FDA plan features a public hearing set for May 31 to gather stakeholder input.

More than half the country has legalized marijuana use in one form or another.